Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
As of April 2025 Baxter has a market cap of C$21.50 Billion. This makes Baxter the world's 1182th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$21.50 B | 0.54% |
2024 | C$21.39 B | -17.76% |
2023 | C$26.01 B | -25.39% |
2022 | C$34.86 B | -36.35% |
2021 | C$54.77 B | 4.81% |
2020 | C$52.26 B | -5.46% |
2019 | C$55.27 B | 20.18% |
2018 | C$45.99 B | 3.88% |
2017 | C$44.27 B | 36.62% |
2016 | C$32.41 B | 11.83% |
2015 | C$28.98 B | -37.17% |
2014 | C$46.13 B | 14.74% |
2013 | C$40.20 B | 11.04% |
2012 | C$36.20 B | 27.58% |
2011 | C$28.37 B | -3.42% |
2010 | C$29.38 B | -20.81% |
2009 | C$37.10 B | -8.18% |
2008 | C$40.41 B | 9.99% |
2007 | C$36.73 B | 4.57% |
2006 | C$35.13 B | 28.26% |
2005 | C$27.39 B | 6.85% |
2004 | C$25.63 B | 5.41% |
2003 | C$24.32 B | -8.27% |
2002 | C$26.51 B | -48.18% |
2001 | C$51.16 B | 31.9% |
2000 | C$38.79 B | 47.55% |
1999 | C$26.29 B | -7.14% |
1998 | C$28.31 B | 40.29% |
1997 | C$20.18 B | 31.91% |
1996 | C$15.29 B |
On Apr 23rd, 2025 the market cap of Baxter was reported to be: